Literature DB >> 28676432

Pathophysiological mechanisms involved in the relationship between diabetes and major depressive disorder.

Gislaine Z Réus1, Maria Augusta B Dos Santos2, Ana Paula Strassi2, Helena M Abelaira2, Luciane B Ceretta3, João Quevedo4.   

Abstract

Diabetes mellitus (DM) and major depressive disorder (MDD) are diseases that are expanding globally. Separately, each presents with several comorbidities for patients. When the two diseases present simultaneously in the same subject, there is a drastic worsening in the quality of life of the patient. This study reviewed the literature relating to the relationship between MDD and DM, bringing forward studies showing that DM develops due to MDD, and others that report the opposite. According to the studies reviewed, DM and MDD are both debilitating conditions that are associated with significant morbidity, mortality, and healthcare costs. When these two diseases coexist, the association results in a decreased adherence to treatment, poor metabolic control, higher rates of complications, a decrease in the quality of life for the patient, increased healthcare use and cost, increased disability and lost productivity, and an increased risk of death. Therefore, it becomes essential that there are larger studies targeting the association of these two diseases, as for the patient, preventing even one of them will ensure improvements in their quality of life.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Hypothalamic-pituitary-adrenal axis; Major depressive disorder; Monoamines

Mesh:

Year:  2017        PMID: 28676432     DOI: 10.1016/j.lfs.2017.06.025

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

Review 1.  Psychosocial aspects of diabetes management: dilemma of diabetes distress.

Authors:  Ruqiya Shama Tareen; Kinza Tareen
Journal:  Transl Pediatr       Date:  2017-10

Review 2.  Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.

Authors:  Teodor T Postolache; Laura Del Bosque-Plata; Serge Jabbour; Michael Vergare; Rongling Wu; Claudia Gragnoli
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-02-06       Impact factor: 3.568

3.  Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action.

Authors:  Yane Costa Chaves; Karina Genaro; José Alexandre Crippa; Joice Maria da Cunha; Janaína Menezes Zanoveli
Journal:  Metab Brain Dis       Date:  2021-01-19       Impact factor: 3.584

4.  Antidepressant effects of cherry leaf decoction on a chronic unpredictable mild stress rat model based on the Glu/GABA-Gln metabolic loop.

Authors:  Chuan Jiang; Hua Wang; Jiaying Qi; Jinghan Li; Qianqian He; Chaonan Wang; Yonggang Gao
Journal:  Metab Brain Dis       Date:  2022-10-01       Impact factor: 3.655

Review 5.  IDO and TDO as a potential therapeutic target in different types of depression.

Authors:  Yanjie Qin; Nanxi Wang; Xinlin Zhang; Xuemei Han; Xuejia Zhai; Yongning Lu
Journal:  Metab Brain Dis       Date:  2018-07-16       Impact factor: 3.584

6.  Chronic Stress Disturbs Metabolome of Blood Plasma and Urine in Diabetic Rats.

Authors:  Yu Ren; Cheng-Hua Yang; Zhu-Man Li; Zhen Yang; Zhi-Jun Xiao; Jing-Jing Duan; Ting Zhou; Feng Xu
Journal:  Front Psychiatry       Date:  2018-10-23       Impact factor: 4.157

7.  Venlafaxine Caffeic Acid Salt: Synthesis, Structural Characterization, and Hypoglycemic Effect Analysis.

Authors:  Hongmei Yu; Yong Zhang; Cheng Xing; Ying Wang; Hailu Zhang; Ningbo Gong; Yang Lu; Guanhua Du
Journal:  ACS Omega       Date:  2021-05-17

Review 8.  Pharmacological effects of berberine on mood disorders.

Authors:  Jie Fan; Kun Zhang; Yang Jin; Bingjini Li; Shuohui Gao; Jiaming Zhu; Ranji Cui
Journal:  J Cell Mol Med       Date:  2018-11-18       Impact factor: 5.310

9.  Continuity of Care and the Quality of Life among Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study in Taiwan.

Authors:  Pei-Lun Hsieh; Fu-Chi Yang; Yi-Fang Hu; Yi-Wen Chiu; Shu-Yuan Chao; Hsiang-Chu Pai; Hsiao-Mei Chen
Journal:  Healthcare (Basel)       Date:  2020-11-14

Review 10.  Inflammasomes as therapeutic targets in human diseases.

Authors:  Yangxin Li; Hui Huang; Bin Liu; Yu Zhang; Xiangbin Pan; Xi-Yong Yu; Zhenya Shen; Yao-Hua Song
Journal:  Signal Transduct Target Ther       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.